Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 636,056 | 338,126 | 413,738 | 750,269 | -221,760 |
| Depreciation Amortization | 74,909 | 52,686 | 41,204 | 36,940 | 31,082 |
| Income taxes - deferred | -121,623 | -53,276 | 62,195 | -340,156 | 0 |
| Accounts receivable | -491,421 | -34,927 | -245,472 | -588,398 | -21,118 |
| Other Working Capital | 229,827 | 15,578 | -190,669 | -672,799 | -18,913 |
| Other Operating Activity | 1,003,032 | 434,248 | 507,600 | 739,529 | 89,027 |
| Operating Cash Flow | $1,330,780 | $752,435 | $588,596 | $-74,615 | $-141,682 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -229,668 | -87,771 | -199,132 | -31,736 | 185,688 |
| PPE Investments | -677,933 | -333,006 | -156,323 | -49,337 | -57,217 |
| Investing Cash Flow | $-907,601 | $-420,777 | $-355,455 | $-81,073 | $128,471 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 27,373 | -1,095 | N/A | N/A | 391,107 |
| Debt Repayment | -741,307 | -515,191 | -2,024 | -2,203 | -119,167 |
| Common Stock Issued | 206,358 | 126,045 | 57,393 | 63,549 | 137,387 |
| Common Stock Repurchased | -160,537 | -267,584 | -195,087 | -163,300 | -25,078 |
| Other Financing Activity | 405,317 | 439,278 | 211,909 | 4,308 | 0 |
| Financing Cash Flow | $-262,796 | $-218,547 | $72,191 | $-97,646 | $384,249 |
| Beginning Cash Position | 648,719 | 535,608 | 230,276 | 483,610 | 112,572 |
| End Cash Position | 809,102 | 648,719 | 535,608 | 230,276 | 483,610 |
| Net Cash Flow | $160,383 | $113,111 | $305,332 | $-253,334 | $371,038 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,330,780 | 752,435 | 588,596 | -74,615 | -141,682 |
| Capital Expenditure | -677,933 | -333,006 | -156,323 | -49,337 | -57,217 |
| Free Cash Flow | 652,847 | 419,429 | 432,273 | -123,952 | -198,899 |